395 related articles for article (PubMed ID: 28732069)
1. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
Brun P; Scarpa M; Marchiori C; Sarasin G; Caputi V; Porzionato A; Giron MC; Palù G; Castagliuolo I
PLoS One; 2017; 12(7):e0181863. PubMed ID: 28732069
[TBL] [Abstract][Full Text] [Related]
2.
Brun P; Qesari M; Marconi PC; Kotsafti A; Porzionato A; Macchi V; Schwendener RA; Scarpa M; Giron MC; Palù G; Calistri A; Castagliuolo I
Front Cell Infect Microbiol; 2018; 8():74. PubMed ID: 29600197
[No Abstract] [Full Text] [Related]
3. Herpes simplex virus type 1 infection of the rat enteric nervous system evokes small-bowel neuromuscular abnormalities.
Brun P; Giron MC; Zoppellaro C; Bin A; Porzionato A; De Caro R; Barbara G; Stanghellini V; Corinaldesi R; Zaninotto G; Palù G; Gaion RM; Tonini M; De Giorgio R; Castagliuolo I
Gastroenterology; 2010 May; 138(5):1790-801. PubMed ID: 20102717
[TBL] [Abstract][Full Text] [Related]
4. Saccharomyces boulardii CNCM I-745 modulates the microbiota-gut-brain axis in a humanized mouse model of Irritable Bowel Syndrome.
Constante M; De Palma G; Lu J; Jury J; Rondeau L; Caminero A; Collins SM; Verdu EF; Bercik P
Neurogastroenterol Motil; 2021 Mar; 33(3):e13985. PubMed ID: 32955166
[TBL] [Abstract][Full Text] [Related]
5. Modulation of 5-fluorouracil activation of toll-like/MyD88/NF-κB/MAPK pathway by Saccharomyces boulardii CNCM I-745 probiotic.
Justino PFC; Franco AX; Pontier-Bres R; Monteiro CES; Barbosa ALR; Souza MHLP; Czerucka D; Soares PMG
Cytokine; 2020 Jan; 125():154791. PubMed ID: 31401369
[TBL] [Abstract][Full Text] [Related]
6. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trial.
Abbas Z; Yakoob J; Jafri W; Ahmad Z; Azam Z; Usman MW; Shamim S; Islam M
Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):630-9. PubMed ID: 24722560
[TBL] [Abstract][Full Text] [Related]
7. Effects of
West C; Stanisz AM; Wong A; Kunze WA
World J Gastroenterol; 2016 Dec; 22(48):10532-10544. PubMed ID: 28082805
[TBL] [Abstract][Full Text] [Related]
8. Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study.
Bustos Fernández LM; Man F; Lasa JS
Dig Dis; 2023; 41(5):798-809. PubMed ID: 36630947
[TBL] [Abstract][Full Text] [Related]
9. Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota.
Wang C; Li W; Wang H; Ma Y; Zhao X; Zhang X; Yang H; Qian J; Li J
BMC Microbiol; 2019 Nov; 19(1):246. PubMed ID: 31694526
[TBL] [Abstract][Full Text] [Related]
10. Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury.
D'Antongiovanni V; Antonioli L; Benvenuti L; Pellegrini C; Di Salvo C; Calvigioni M; Panattoni A; Ryskalin L; Natale G; Banni S; Carta G; Ghelardi E; Fornai M
Br J Pharmacol; 2023 Dec; 180(24):3215-3233. PubMed ID: 37519261
[TBL] [Abstract][Full Text] [Related]
11. The effects of
Liu J; Ren H; Yuan F; Shao M; Luo H
PeerJ; 2022; 10():e14390. PubMed ID: 36438584
[TBL] [Abstract][Full Text] [Related]
12.
Briand F; Sulpice T; Giammarinaro P; Roux X
Benef Microbes; 2019 May; 10(5):555-567. PubMed ID: 31090460
[TBL] [Abstract][Full Text] [Related]
13. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats.
Yu ZC; Cen YX; Wu BH; Wei C; Xiong F; Li DF; Liu TT; Luo MH; Guo LL; Li YX; Wang LS; Wang JY; Yao J
World J Gastroenterol; 2019 Aug; 25(29):3956-3971. PubMed ID: 31413530
[TBL] [Abstract][Full Text] [Related]
14. Adenosine-mediated enteric neuromuscular function is affected during herpes simplex virus type 1 infection of rat enteric nervous system.
Zoppellaro C; Bin A; Brun P; Banzato S; Macchi V; Castagliuolo I; Giron MC
PLoS One; 2013; 8(8):e72648. PubMed ID: 24015268
[TBL] [Abstract][Full Text] [Related]
15. Diversity of
Czerucka D; Rampal P
World J Gastroenterol; 2019 May; 25(18):2188-2203. PubMed ID: 31143070
[TBL] [Abstract][Full Text] [Related]
16. Colonic Hypermotility in a Rat Model of Irritable Bowel Syndrome Is Associated with Upregulation of TMEM16A in Myenteric Plexus.
Lin MJ; Yu BP
Dig Dis Sci; 2018 Dec; 63(12):3329-3338. PubMed ID: 30155840
[TBL] [Abstract][Full Text] [Related]
17. Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice.
Justino PF; Melo LF; Nogueira AF; Costa JV; Silva LM; Santos CM; Mendes WO; Costa MR; Franco AX; Lima AA; Ribeiro RA; Souza MH; Soares PM
Br J Nutr; 2014 May; 111(9):1611-21. PubMed ID: 24503021
[TBL] [Abstract][Full Text] [Related]
18. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition.
Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J
J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870
[TBL] [Abstract][Full Text] [Related]
19. [Saccharomyces boulardii CNCM I-745 - the medicinal yeast improves intestinal enzyme function].
Moré MI
MMW Fortschr Med; 2019 Mar; 161(Suppl 4):20-24. PubMed ID: 30895510
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system.
Brun P; Giron MC; Qesari M; Porzionato A; Caputi V; Zoppellaro C; Banzato S; Grillo AR; Spagnol L; De Caro R; Pizzuti D; Barbieri V; Rosato A; Sturniolo GC; Martines D; Zaninotto G; Palù G; Castagliuolo I
Gastroenterology; 2013 Dec; 145(6):1323-33. PubMed ID: 23994200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
